Ruzam - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbsphypodermic solution

Composition:

Active substance: extract from the culture of the thermophilic strain of Staphylococcus aureus (Staphyloccocus aureus, strain C-2).

Excipients: solution of sodium chloride for injection 0.9%, phenol 0.025-0.05%.

Description:

Transparent, colorless or slightly colored liquid, with a slight smell of phenol.

Pharmacotherapeutic group:antiallergic

ATX: & nbsp

Other immunostimulants

Pharmacodynamics:

Has anti-inflammatory and anti-allergic effect. Reduces edema of the mucous membranes and skin, reduces the content of eosinophils and degranulated mast cells in the inflammation focus and increases the concentration of secretory immunoglobulin class A in the mucous membranes, thereby increasing their resistance to infection. Reduces the content of markers of allergic inflammation: total immunoglobulin class E in the blood and nitric oxide in the exhaled air.

Indications:

Seasonal (pollinosis) and all-the-year-round allergic rhinitis, bronchial asthma, urticaria and Quinnke edema, atopic and other allergic dermatitis, frequent respiratory infections.

Contraindications:

Hypersensitivity to the drug, pregnancy and the period of breastfeeding, children under 4 years old, acute infection, active tuberculosis, uncompensated diseases of internal organs.

Carefully:

If there are foci of chronic infection (chronic tonsillitis, sinusitis) due to the possibility of their exacerbation.

Dosing and Administration:

Subcutaneously adults and children over 6 years old to 0.2 ml once a week, children from 4 to 6 years 0.1 ml once a week; course 5-10 weeks.

During the year there may be conducted from 1 to 4 courses.

With pollinosis, the drug is injected 6-8 weeks before the flowering period of the allergenic plant; at Frequent respiratory infections should be prevented in the spring and in the fall.

Side effects:

Increase in body temperature to subfebrile digits, weakness, exacerbation of chronic infection, short-term coughing in chronic bronchitis, increased skin rash with skin allergies.

These symptoms are usually mild and transitory, do not require drug withdrawal.

Overdose:

No cases of overdose have been reported.

Interaction:

No interactions of RUZAM® with other drugs have been reported.

RUZAM® can be prescribed together with antihistamines, glucocorticosteroids or antibiotics.

Special instructions:

The solution remaining in the ampoule should not be used.

Effect on the ability to drive transp. cf.and fur:The drug has no effect on the performance of potentially hazardous activities requiring special attention and quick reactions (driving, etc.).

Form release / dosage:Solution for subcutaneous administration.

Packaging:

By 0.2 ml or 0.5 ml in ampoules of colorless or light-shielded glass.

5 ampoules in the outline of the cell.

For 1 or 2 contour packs with a knife or scarifier: ampoule (or without them), together with instructions for use in a pack of cardboard.

Storage conditions:

In a place protected from light and not accessible to children, at a temperature of 4 to 20 ° C.

Shelf life:

4 years.

Do not use after the time specified on the package.

Terms of leave from pharmacies:On prescription

Registration number:LS-000791

Date of registration:25.11.2010

The owner of the registration certificate:RUZAM-M, LLC RUZAM-M, LLC Russia

Manufacturer: & nbsp

PIPVE them. M.P. Chumakova RAMS FSUE Russia

Information update date: & nbsp09.03.2016

Illustrated instructions

Instructions

Ruzam® (Rusam)